Filing Analysis

📢 Regulation FD Disclosure Filed May 15, 2026
⚪ LOW

Buda Juice, Inc. reported its financial results for the first quarter ended March 31, 2026, via a press release. The filing serves as a standard quarterly earnings disclosure under Item 2.02.

📋 Key Facts

  • Financial results for the quarter ended March 31, 2026, were reported on May 13, 2026.
  • The report was filed under Item 2.02 (Results of Operations and Financial Condition).
  • Buda Juice, Inc. is an emerging growth company listed on the NYSE American under the symbol BUDA.
  • The press release was furnished as Exhibit 99.1 and is not deemed 'filed' for Section 18 liability purposes.
💸 Securities Offering Filed Jan 22, 2026
⚪ LOW

Buda Juice, Inc. announced that underwriters have fully exercised the over-allotment option related to its recent Initial Public Offering (IPO). This resulted in the issuance of additional shares and a capital influx for the company.

📋 Key Facts

  • Date of event: January 21, 2026
  • Underwriter (MDB CAPITAL/Public Ventures, LLC) exercised over-allotment option in full.
  • Additional gross proceeds received: $2,999,992.50.
  • Number of additional shares issued: 399,999 shares of common stock.
💸 Securities Offering Filed Jan 09, 2026
🟡 MEDIUM

Buda Juice, Inc. has announced the pricing of an initial public offering (IPO) involving 2,666,667 shares at $7.50 per share, aiming to raise approximately $20 million in gross proceeds. The company also adopted a new 2025 Equity Incentive Plan and commenced trading on the NYSE American.

🚩 Red Flags

  • Underwriter warrants represent potential future dilution for existing shareholders at a premium price ($9.375).

📋 Key Facts

  • IPO pricing set at $7.50 per share for 2,666,667 shares of common stock.
  • Gross proceeds from the offering are estimated at $20 million before discounts and expenses.
  • Underwriter warrants issued to MDB CAPITAL (Public Ventures, LLC) for 266,667 shares (10% of the offering).
  • Warrants have an exercise price of $9.375 (125% of the offering price) and expire January 7, 2031.
  • The company adopted the 'Buda Juice, Inc. 2025 Equity Incentive Plan' to attract and retain talent.
  • Commencement of trading on NYSE American occurred around January 8, 2026.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for BUDA

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial